Cite
HARVARD Citation
Zhu, M. et al. (n.d.). Population Pharmacokinetics of Rilotumumab, a Fully Human Monoclonal Antibody Against Hepatocyte Growth Factor, in Cancer Patients. Journal of pharmaceutical sciences. 103 (1), pp. 328-336. [Online].